Quantcast
Last updated on April 16, 2014 at 7:15 EDT

Latest Transplantation medicine Stories

2013-03-09 23:00:49

The goal of the "Cornea Preservation Time Study" is to guarantee donor supply meets future demand by widening the cornea transplant window. Sarasota, FL (PRWEB) March 09, 2013 Center For Sight ophthalmologist William Lahners, M.D., has been selected to participate in the national “Cornea Preservation Time Study” to determine if corneas transplanted up to two weeks after donation work as well as corneas transplanted up to one week after donation. About 40 clinical sites around...

2013-03-01 00:20:43

Plano, Texas locals rally to find a donor for six-year-old Aidan Peterson with an on-site bone marrow donor drive, music, entertainment and more at Henry's Tavern Event March 2, 2013 PLANO, Texas, Feb. 28, 2013 /PRNewswire/ -- Henry's Tavern is hosting a family-friendly bone marrow donor drive Saturday, Mar. 2 from 1-4 p.m. for Aidan Peterson. This Henry's Tavern Event will help Aidan and countless others who desperately need a lifesaving bone marrow transplant - are you the one to...

2013-02-19 08:31:46

RESEARCH TRIANGLE PARK, N.C., Feb. 19, 2013 /PRNewswire/ -- Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today released data from presentations at the BMT Tandem Meetings supporting the broad spectrum antiviral activity and emerging safety profile of CMX001. CMX001 is an oral nucleotide lipid-conjugate anticipated to start a Phase 3 study later this year. "These findings demonstrate CMX001's potential to be a safe and...

2013-02-17 23:01:20

Bone augmentation is often necessary prior to implant surgery, and Dr. Gayle Bradshaw is now accepting bone graft patients lacking the jaw bone strength to support dental implants. The Woodlands, TX (PRWEB) February 17, 2013 Dr. Gayle Bradshaw offers bone grafting as a means of augmenting available bone so that installing dental implants is possible, and she is now accepting new patients for this modern dental procedure. When teeth are missing, the bite can be impacted and normal eating...

2013-02-13 12:25:39

In the news release, The Expected Approval of Velcade Will Be a Significant Driver of Growth in the Graft Versus Host Disease Drug Market, issued 07-Feb-2013 by Decision Resources over PR Newswire, we are advised by the company that there have been several revisions to the release. The complete, corrected release follows: Physicians' Adoption of Velcade for the Treatment of Chronic Graft Versus Host Disease Will Drive Growth In This Market Through 2021 Uptake of Velcade in the First-Line...

2013-02-12 23:01:41

STEMSOFT and the CBMTG are pleased to work together to create a national registry of patients who have undergone blood and marrow transplants in Canada. Vancouver, BC (PRWEB) February 12, 2013 The Canadian Blood and Marrow Transplant Group (“CBMTG”) is pleased to announce a partnership with STEMSOFT Software Inc. (“STEMSOFT”) that will result in a national registry of patients who have undergone blood and marrow transplants in Canada. “This registry will...

2013-02-11 08:25:04

KENNESAW, Ga., Feb. 11, 2013 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its receipt of four new issued patents related to tissue grafts derived from the placenta. The U.S. Patent Office has issued to MiMedx U.S. Patent Number 8,357,403, "Placental Tissue Grafts," with a grant date of January 22, 2013. The U.S Patent...

2013-02-07 23:04:20

Can stem cells provide an answer to the perplexing question of how to ensure long-term survival of transplanted kidneys? The results of a new Phase 1 clinical trial say maybe so. Details of the trial, conducted by researchers at Leiden University Medical Center, The Netherlands, are published in the current issue of STEM CELLS Translational Medicine. Durham, NC (PRWEB) February 07, 2013 Kidney transplants have long been the treatment of choice for many patients with end-stage renal disease,...

2013-02-07 12:25:08

BURLINGTON, Mass., Feb. 7, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the expected supplemental approval of Millennium (Takeda)/Johnson & Johnson's Velcade for the treatment of chronic graft versus host disease (GVHD) will be a significant driver of growth in the GVHD market through 2021. In particular, Velcade's uptake in the first-line treatment setting will displace lower-priced...

2013-02-04 14:44:19

Epidermal growth factor has been found to speed the recovery of blood-making stem cells after exposure to radiation, according to Duke Medicine researchers. The finding could open new options for treating cancer patients and victims of dirty bombs or nuclear disasters. Reported in the Feb. 3, 2013, issue of the journal Nature Medicine, the researchers explored what had first appeared to be an anomaly among certain genetically modified mice with an abundance of epidermal growth factor in...


Latest Transplantation medicine Reference Libraries

Bone Marrow Transplantation (journal)
2012-06-04 20:00:41

Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...

More Articles (1 articles) »